Pretty dull action on the CFU SP front..goes without saying. IMHO we are still seeing a manipulation of sorts with party A selling to its associate party B.. running the SP down.... if your selling to effectively yourself it dulls the pain of any SP drop and creates accumulation opportunities as the various ma's n pa's sell out in despair. This has been underway for many months and profilled at length here on HC. Take comfort in the number of sellers vrs buyers..around 10/1 in favor of the buys..shows us that the top 5 layers of sells are potentially a handful of entities, or possibly one or two while the buyers are genuine and in volume. Somewhere in the buy stack will be the catcher from the sell team waiting for a slip on the Dow to uproot some holders.
On a broader front, Ceres in the UK has suffered 6 months of slow decline so I guess we can take from that some disinterest in the sector while the money chases the spillage of the blue chips after the GFC.
The likes of Bloom will obviously assist CFU in its journey as all news is good and the comparisons to CFU will ultimately be favorable. Bloom are years away from a small domestic rig and that presents particular hurdles of scale that CFU decided to confront as a priority.
Don't know if CE approval is going to really be a SP driver but it will be a hurdle against any volume orders of bluegen becoming official but bear in mind that the PRIMARY mCHP product for CFU, NetGen plus, already has CE approval.
Volume orders will be the driver and it will only take one to get the mass production threshold to a point where the retail price will satisfy the mass market take up pricing criteria. From memory CFU production will become cost effective at around 5000 units.
Hold tight folks..feed in tariffs, expansion of partners base, demo units, factories up n running.. blue skies are coming so wait for the show.
CFU Price at posting:
16.3¢ Sentiment: Buy Disclosure: Held
